| Catalog Number |
ACMA00065304 |
| Description |
Pemigatinib is intended for Pharmaceuticals applications: is a selective fibroblast growth factor (FGFR) inhibitorused for the treatment of bile duct cancer and recently approved in US for the treatment of relapsed or refractory myeloid/lymphoid neoplasms (MLNs). It acts as a Tyrosine Kinase Inhibitor (with antitumour activity). All information about [2H8]-Pemigatinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Molecular Weight |
495.56 |
| Molecular Formula |
C24H27F2N5O4 |
| Purity |
≥95% |
| Isotopic Enrichment |
98% 2H |
| Stability |
≥1 year |
| Unlabeled CAS |
1513857-77-6 |
Please kindly note that our products and services are for research use only.
